Vasoactive intestinal peptide stimulation of human trabecular meshwork cell growth

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 13, 1997, Pages 2781-2789

  Koh, Shay Whey M ^a   Yeh, Tse Hsiang ^a   Morris, Steven M ^a   Leffler, Margaret ^a   Higginbotham, Eve J ^a   Brenneman, Douglas E ^b   Yue, Beatrice Y J T ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Argon laser trabeculoplasty; Cell proliferation; Proliferating cell nuclear antigen; Trabecular meshwork cells; Vasoactive intestinal peptide

Indexed keywords

CYCLINE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; GROWTH STIMULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MITOSIS; PRIORITY JOURNAL; TRABECULAR MESHWORK; TRABECULOPLASTY;

ADOLESCENT; ADULT; AGED; CELL COUNT; CELL DIVISION; CELLS, CULTURED; CHILD; CORNEA; DOSE-RESPONSE RELATIONSHIP, DRUG; GROWTH SUBSTANCES; HUMANS; IMMUNOENZYME TECHNIQUES; LASER SURGERY; MITOSIS; ORGAN CULTURE TECHNIQUES; PROLIFERATING CELL NUCLEAR ANTIGEN; SCLERA; TRABECULAR MESHWORK; TRABECULECTOMY; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0031455574     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Klini MM, Leibowitz HM, Colton T, Nickerson R, Ganley J, Dawber TR. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration and open-angle glaucoma in the Framingham eye study. Am J Ophthalmol. 1978;85:28-34.
2. Stromberg U. Ocular hypertension: Frequency course and relation to other disorders occurring in glaucoma, as seen from a mass survey of all inhabitants over 40 years of age in a Swedish town. Acta Ophthalmol. 1962;69(Suppl):1.
3. Alvarado J, Murphy C, Polansky J, Juster R. Age-related changes in trabecular meshwork cellularity. Invest Ophthalmol Vis Sci. 1981;21:714-727.
4. Alvarado J, Murphy C, Juster R. Trabecular meshwork cellularity in primary open-angle glaucoma and non-glaucomatous normals. Ophthalmology. 1984;91:564-579.
5. Johnson D. Do trabecular meshwork cells replicate? Invest Ophthalmol Vis Sci. 1986;27(Suppl):210.
6. 3H-thymidine labelling: An autoradiographic study in cats. Curr Eye Res. 1992;11:297-306.
7. Dueker DK, Norberg M, Johnson DH, Tschumper RC, Feeney-Burns L. Stimulation of cell division by argon and Nd:YAG laser trabeculoplasty in cynomolgus monkeys. Invest Ophthalmol Vis Sci. 1990;31:115-124.
8. Oh YG, Rosenquist RC. Laser treatment in glaucoma. In: Higginbotham EJ, Lee DA, eds. Management of Difficult Glaucoma. Cambridge, MA: Blackwell Scientific; 1994:299-315.
9. Wise JB, Witter SL. Argon laser therapy for open angle glaucoma: A pilot study. Arch Ophthalmol. 1979;97: 785-789.
10. Schwartz AL, Whitten ME, Bleimen B, et al. Argon laser trabecular surgery in uncontrolled phakic open-angle glaucoma. Ophthalmology. 1981;88:203-212.
11. Acott TS, Samples JR, Bradley JM, Bacon DR, Bylsma SS, Van Buskirk EM. Trabecular repopulation by anterior trabecular meshwork cells after laser trabeculoplasty. Am J Ophthalmol. 1989;107:1-6.
12. Bylsma SS, Samples JR, Acott TS, Van Buskirk, EM. Trabecular cell division after argon laser trabeculoplasty. Arch Ophthalmol. 1988;106:544-547.
13. Maruo T, Matsuo H, Otani T, Mochizuki M. Role of epidermal growth factor (EGF) and its receptor in the development of the human placenta. Reprod Fertil Dev. 1995;7:1465-1470.
14. Ringheim GE. Mitogenic effects of interleukin-5 on microglia. Neurosci Lett. 1995;201:131-134.
15. Taylor AW, Streilin JW, Cousin SW. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol. 1994;153:1080-1086.
16. Stone R, Tervo T, Tervo K, Tarkkanen A. Vasoactive intestinal polypeptide-like immunoreactive nerves to the human eye. Acta Ophthalmol. 1986;64:12-18.
17. Brenneman DE, Nicol T, Warren D, Bowers LM. Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglia mitogen. J Neurosci Res. 1990;25:386-394.
18. Gozes I, Brenneman DE. VIP: Molecular biology and neurobiological function. Mol Neurobiol. 1989;3:201-236.
19. Gozes I, Brenneman DE. Neuropeptides as growth and differentiation factors in general and VIP in particular. J Mol Neurosci. 1993;4:1-9.
20. Gozes I, Brenneman DE, Lilling G, Davidson A, Moody TW. Neuropeptide regulation of mitosis. Ann N Y Acad Sci. 1994;739:253-261.
21. Koh S-WM, Kane GJ VIP stimulates proliferation and differentiation of the cultured retinal pigment epithelium with disparate potencies. Cell Biol Int Rep. 1992;16:175-183.
22. Haegerstrand A, Jonzon B, Dalsgaard C-J, Nilsson J Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured keratinocytes. Proc Natl Acad Sci U S A. 1989;86:9553-5996.
23. Mitsuhashi M, Payan DG. The mitogenic effects of vasoactive neuropeptides on cultured smooth muscle cell lines. Life Sci. 1987;40:853-861.
24. Gressens P, Hill JM, Gozes I, Fridkin M, Brenneman EE. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature. 1993;362:155-158.
25. Pincus DW, DiCicco-Bloom EM, Black IB. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature. 1990;343:564-567.
26. Brenneman DE, Eiden LE. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc Natl Acad Sci U S A. 1986;83:1159-1162.
27. Gozes I, Bardea A, Reshef A, et al. Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide. Proc Natl Acad Sci U S A. 1996;93:427-432.
28. Brenneman DE, Westbrook G, Fitzgerald SP, et al. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 1988;335:639-642.
29. Koh S-WM, Yue BYJT. Effects of agonists on the intracellular cyclic AMP concentration in monkey trabecular meshwork cells. Curr Eye Res. 1988;7:75-80.
30. Yue BYJT, Higginbotham E, Chang IL. Ascorbic acid modulates the production of fibronectin and laminin by cells from an eye tissue: Trabecular meshwork. Exp Cell Res. 1990;187:65-68.
31. Higginbotham E, Yue BYJT, Crean E, Peace J. Effects of ascorbic acid on trabecular meshwork cells in culture. Exp Eye Res. 1988;46:507-516.
32. Yue BYJT, Einer VM, Elner SG, Davis HR. Lysosomal enzyme activities in cultured trabecular meshwork cells. Exp Eye Res. 1987;44:891-897.
33. Zhou L. Zhang SR, Yue BYJT. Adhesion of human trabecular meshwork cells to extracellular proteins. Invest Ophthalmol Vis Sci. 1996;37:104-113.
34. Gozes I, Meltzer E, Rubinrout S, Brenneman EE, Fridkin M. Vasoactive intestinal peptide potentiate sexual behavior: Inhibition by novel antagonist. Endocrinology. 1989;125:2945-2949.
35. Moody TW, Zia F, Draoui M, et al. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth. Proc Natl Acad Sci U S A. 1993;90:4345-4349.
36. Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): Structural conservation and the detection of a nuclear form, J Cell Sci. 1990;96:121-129.
37. Acott TS, Kingsley PD, Samples JR, Van Buskirk EM. Human trabecular meshwork organ culture: Morphology and glycosaminoglycan synthesis. Invest Ophthalmol Vis Sci. 1988;29:90-100.
38. Koh, S-WM, Chader GJ Elevation of intracellular cyclic AMP by vasoactive intestinal peptide and glucagon in the retinal pigment epithelium. J Neurochem. 1984;43:1522-1526.
39. Redfern N, Israel P, Bergsma D, Robison WG Jr, Whikehart D, Chader G. Neural retinal and pigment epithelial cells in cultures: Pattern of differentiation and effects of prostaglandins and cyclic-AMP on pigmentation. Exp Eye Res. 1976;22:559-568.
40. MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem. 1995;64:345-373.
41. Comb M, Birnberg NC, Seasholtz A, Herbert E, Goodman HM. A cyclic AMP- and phorbol ester-inducible DNA element. Nature. 1986;323:353-356.
42. Bravo, R, Neuberg M, Burckhardt J, Almendral J, Wallich R, Muller R. Involvement of common and cell type-specific pathways in c-fos gene control: Stable induction by cAMP in macrophages. Cell. 1987;48:251-260.
43. Cripps MM, Thompson HW, Beuerman RW. Vasoactive intestinal peptide induces primary response gene expression in lacrimal gland. Adv Exp Med Biol. 1994;350:225-230.
44. Bradley JMB, Parshley DE, Samples JR, Acott TS. Trabecular response to laser trabeculoplasty is mediated a factor produced after treatment. Invest Ophthalmol Vis Sci 1996;37(suppl):151.
45. Wilson SE, Schultz GS, Chegini N, Weng J, He Y-G. Epidermal growth factor, transforming growth factor alpha, transforming growth factor beta, acidic fibroblast growth factor, basic fibroblast growth factor, and interleukin-1 proteins in the cornea. Exp Eye Res. 1994;59:63-72.
46. Brenneman DE, Schultzberg M, Bartfai T, Gozes I. Cytokine regulation of neuronal survival. J Neurochem. 1992;8:454-460.
47. Maimone D, Cioni C, Rosa S, Macchia G, Aloisi F, Annunziata P. Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: Synergism with IL-1 beta and TNF alpha. J Neuroimmunol. 1993;47:73-82.
48. Gottschall PE, Tatsuno I, Arimura A. Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: Synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PA-; CAP). Brain Res. 1994;637:197-203.
49. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci. 1988;8:2485-2490.